Karine Le Malicot

Prognostic Value of<i>BRAF </i>and <i>KRAS</i> Mutations in MSI and MSS Stage III Colon Cancer

Karine Le Malicot, Qian Shi, Frédérique Penault-Llorca et al. · JNCI Journal of the National Cancer Institute · 2016 · 262 citations · Full text

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 163 citations · Full text

Solid Cancer Patients, Cancer Epidemiology, Disease Risk Assessment +12

Prognostic Effect of<i>BRAF</i>and<i>KRAS</i>Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab

Aziz Zaanan, Karine Le Malicot, Catherine Julié et al. · JAMA Oncology · 2016 · 145 citations

Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy

Aziz Zaanan, Qian Shi, Steven R. Alberts et al. · JAMA Oncology · 2017 · 144 citations · Full text

Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab

Anthony Dohan, B. Gallix, Boris Guiu et al. · Gut · 2019 · 135 citations